PerkinElmer Launches New Assay Development Service for Advanced Cellular Science and Drug Discovery

WALTHAM, Mass.—(BUSINESS WIRE)—Aug. 7, 2007—PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced the launch of a comprehensive assay development service for high-performance, highly sensitive assays in advanced cellular science and drug discovery research.

Source: PerkinElmer, Inc.